The Efficacy of Sandostatin (Long Acting Release) on Acromegalic Patients: A Study from Northwest Iran
Journal Title: Journal of Clinical and Diagnostic Research - Year 2019, Vol 13, Issue 3
Abstract
ABSTRACT Introduction: Acromegaly is a clinical syndrome resulting from excessive secretion of growth hormone with the approximate prevalence of six cases per million. Somatostatin agonists are the only drug approved which can actually control, to some extent, the secretion of growth hormone after surgery. Short-acting analogues of these compounds should be taken three times a day which is very undesirable. In contrast, long-acting analogues of somatostatin have the market availability for more than one decade, but Iranian physicians have the drug accessibility only within the last few years. Aim: To determine the effects of long-acting analogue octreotide (Sandostatin Long Acting Release (LAR) on the level of Growth Hormone (GH), Insulin-like Growth Factor 1 (IGF-1) and clinical symptoms in patients with acromegaly in the northwest of Iran. Materials and Methods: The level of GH, IGF-1 and clinical symptoms were evaluated after long-acting analogue Sandostatin LAR administration in 40 acromegalic patients with no surgical history or any remarkable improvement in clinical features and IGF-1/GH levels after surgery, referred to outpatient endocrinology sections, Tabriz University of Medical Sciences were included. The serum level of GH and IGF-1 were evaluated using electro-chemiluminescence system before and after 3, 6 and 12-months of drug administration. Repeated measure test was used for statistical analysis. p<0.05 was considered as statistically significant. Results: Use of Sandostatin LAR showed 72.5% and 27.5% absolute and partial recovery, respectively. Mean level of IGF-1 before and after 3, 6 and 12-months treatment were 654.17±199.12, 423.95±228.94, 356.22±169.53, 296.25±110.6 μg/L, respectively, (p<0.001). Additionally, Mean GH level before and after 3, 6 and 12-months treatment were 31.71±3.03, 10.31±5.23, 7.28±3.11 and 6.77±4.38 μg/L, respectively, (p<0.001). Conclusion: Sandostatin LAR treatment may be an effective and proper method for treatment of GH producing adenoma in patients who are not good candidates for surgery or having high GH/ IGF-1 levels after surgery.
Authors and Affiliations
Akbar-Ali Asgarzadeh, Farzad Najafipour, Majid Mobasseri, Seyyed Mehdi Mirtajaddini, Shabnam Rashidi-Rad
Keywords
Related Articles
- EP ID EP582765
- DOI 10.7860/JCDR/2019/37567.12647
- Views 104
- Downloads 0
Validation of the Short Form of the Adherence to Refills and Medications Scale in Iranian Elders with Chronic Disease
ABSTRACT Introduction: Evaluating medication adherence in chronic diseases is important to understand the effectiveness of treatment. A reliable, valid, and practical measure is needed to assess medication adherence for...
Effect of Calcium Hydroxide Based Intracanal Medicaments on the Apical Sealing Ability of Resin Based Sealer and Guttapercha Obturated Root Canals
Introduction: Calcium Hydroxide (CH) is one of the most commonly used intracanal medicaments which can be used with various vehicles. Aim: The aim of this in vitro study was to evaluate the effect of three CH based intra...
Clinical Significance of Presence of Extensor Indicis Brevis Manus – A Case Report
Anatomical variations of additional muscles and tendons are commonly encountered in extensor aspect of forearm and hand during surgeries and dissections. There are reports on different kinds of variations like, extra ten...
Benign Fibrous Histiocytoma: An Uncommon Presentation
Intracranial fibrous histiocytomas are rare; Benign Fibrous Histiocytoma (BFH) being uncommon than its malignant counterpart. BFH comprises fibroblasts and histiocytes without any nuclear pleomorphism or atypia. We prese...
Effect of Maternal Nutritional Status, Socioeconomic Class and Literacy Level on Birth Weight of Babies
ABSTRACT Introduction: The prevalence of Low Birth Weight (LBW) is higher in Asia than elsewhere predominantly because of undernutrition and poor socioeconomic status of mothers. Nearly half of the pregnant women still s...